NCT06634407

Brief Summary

Transcatheter Closure of Patent Ductus Arteriosus to evaluate the outcome of percutaneous transcatheter closure of patent ductus arteriosus in children

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 9, 2024

Completed
16 days until next milestone

Study Start

First participant enrolled

October 25, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

October 22, 2024

Status Verified

October 1, 2024

Enrollment Period

10 months

First QC Date

October 8, 2024

Last Update Submit

October 21, 2024

Conditions

Patent Ductus Arteriosus (PDA)

Outcome Measures

Primary Outcomes (1)

  • outcome of trancathter PDA closure

    outcome of 90 patients with trancatheter PDA closure in pediatrics using post procedure catheter and echocardiography

    3 years

Study Arms (1)

PDA patients

OTHER
Procedure: transcatheter closure

Interventions

transcatheter closurePROCEDURE

using transcatheter closure of PDA to detect outcome of patients with PDA

PDA patients

Eligibility Criteria

Age6 Months - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children with Patent Ductus Arteriosus confirmed by echocardiography
  • aged from 6 months to 16 years underwent percutaneous transcatheter PDA closure at Pediatric Cardiology Unit.

You may not qualify if:

  • Children with PDA younger than 6 months or older than 16 years and that are not candidate for transcatheter closure .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Ductus Arteriosus, Patent

Condition Hierarchy (Ancestors)

Heart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Bassem Eldaba Fares bassem fares

CONTACT

+201220851469basam.13298661@med.aun.edu.eg

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
pediatric resident

Study Record Dates

First Submitted

October 8, 2024

First Posted

October 9, 2024

Study Start

October 25, 2024

Primary Completion

September 1, 2025

Study Completion

September 15, 2025

Last Updated

October 22, 2024

Record last verified: 2024-10